IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 199 filers reported holding IMMUNOGEN INC in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $50,000 | -19.4% | 22,945 | 0.0% | 0.00% | – |
| Q1 2019 | $62,000 | -43.6% | 22,945 | 0.0% | 0.00% | – |
| Q4 2018 | $110,000 | -49.3% | 22,945 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $217,000 | -2.7% | 22,945 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $223,000 | +28.9% | 22,945 | +39.1% | 0.00% | – |
| Q1 2018 | $173,000 | -82.2% | 16,490 | -83.7% | 0.00% | -100.0% |
| Q3 2015 | $972,000 | -43.3% | 101,250 | -15.1% | 0.00% | -33.3% |
| Q2 2015 | $1,715,000 | +60.7% | 119,250 | 0.0% | 0.01% | +50.0% |
| Q1 2015 | $1,067,000 | +53.3% | 119,250 | +4.6% | 0.00% | +100.0% |
| Q4 2014 | $696,000 | -42.4% | 114,050 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $1,208,000 | -10.6% | 114,050 | 0.0% | 0.00% | -20.0% |
| Q2 2014 | $1,351,000 | -20.7% | 114,050 | 0.0% | 0.01% | -28.6% |
| Q1 2014 | $1,703,000 | +7.9% | 114,050 | +5.9% | 0.01% | +16.7% |
| Q4 2013 | $1,579,000 | -13.8% | 107,650 | 0.0% | 0.01% | -25.0% |
| Q3 2013 | $1,832,000 | +2.2% | 107,650 | -0.4% | 0.01% | 0.0% |
| Q2 2013 | $1,793,000 | – | 108,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 1,375,900 | $6,329,000 | 1.08% |
| Redmile Group, LLC | 12,006,979 | $55,232,000 | 1.02% |
| Birchview Capital, LP | 190,000 | $874,000 | 0.53% |
| Fernwood Investment Management, LLC | 179,340 | $825,000 | 0.41% |
| HealthCor Management, L.P. | 1,200,000 | $5,520,000 | 0.23% |
| Grace Capital | 49,500 | $228,000 | 0.20% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $479,000 | 0.19% |
| Virtus ETF Advisers LLC | 79,795 | $367,000 | 0.17% |
| PINNACLE ASSOCIATES LTD | 1,087,034 | $5,000,000 | 0.12% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 100,000 | $460,000 | 0.12% |